Jørgen Bjerggaard Jensen
Clinical trials sponsored by Jørgen Bjerggaard Jensen, explained in plain language.
-
Could a quick chemo course before surgery beat standard bladder cancer treatment?
Disease control CompletedThis study tested whether giving a short, intensive course of chemotherapy (Mitomycin C) directly into the bladder before surgery could reduce the chance of cancer coming back, compared to the standard approach of surgery followed by regular chemo instillations. The trial involve…
Phase: PHASE4 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New bladder cancer surgery could cut recurrence risk
Disease control CompletedThis study tested a new way to remove early-stage bladder tumors called En Bloc resection, where the tumor is taken out in one piece instead of in fragments. The goal was to see if this method gives doctors better tissue samples and more accurate diagnosis, which could lower the …
Phase: NA • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC